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Endothelial cells encounter oxidant stress due to their location in the vascular wall, and because they generate reactive nitrogen species.
Because ascorbic acid is likely involved in the antioxidant defenses of these cells, we studied the mechanisms by which cultures of EA.hy926
endothelial cells recycle the vitamin from its oxidized forms. Cell lysates reduced the ascorbate free radical (AFR) by both NADH- and
NADPH-dependent mechanisms. Most NADH-dependent AFR reduction occurred in the particulate fraction of the cells. NADPH-dependent
reduction resembled that due to NADH in having a high affinity for the AFR, but was mediated largely by thioredoxin reductase. Reduction
of dehydroascorbic acid (DHA) required GSH and was both direct and enzyme dependent. The latter was saturable, half-maximal at 100 AM
DHA, and comparable to rates of AFR reduction. Loading cells to ascorbate concentrations of 0.3–1.6 mM generated intracellular DHA
concentrations of 20–30 AM, indicative of oxidant stress in culture. Whereas high-affinity AFR reduction is the initial and likely the
preferred mechanism of ascorbate recycling, any DHA that accumulates during oxidant stress will be reduced by GSH-dependent
mechanisms.D 2003 Elsevier Science B.V. All rights reserved.Keywords: Ascorbic acid; Ascorbate free radical; Dehydroascorbic acid; Oxidant stress; Endothelial cell1. Introduction
Endothelial cells, which form the barrier between the
bloodstream and underlying tissues, are exposed to poten-
tially damaging oxidant stress from both compartments. Of
several lines of defense against oxidant stress in the vascular
bed, ascorbic acid is one of the most sensitive, both in
plasma [1] and in cells [2]. The ability of endothelial cells to
regenerate ascorbate from its oxidized forms, dehydroascor-
bic acid (DHA) and the ascorbate free radical (AFR), may
be important not only for the ascorbate economy of the cell,
but also may determine the amount of the vitamin available
for passage across the endothelium. Bovine aortic endothe-
lial cells reduce DHA, the two-electron oxidized form of
ascorbate, by GSH-dependent mechanisms [3]. GSH
reduces DHA directly to ascorbate [4], or serves as a0167-4889/03/$ - see front matter D 2003 Elsevier Science B.V. All rights reserv
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E-mail address: james.may@vanderbilt.edu (J.M. May).cofactor for GSH-dependent enzymes, such as glutaredoxin
or protein disulfide isomerase [5]. However, whether endo-
thelial cells recycle ascorbate from the AFR, and how this
compares to DHA reduction is unknown.
DHA concentrations in plasma are low, in the range of
0–2 AM, or about 1–2% of ascorbate concentrations [6–
9]. Plasma DHA concentrations are increased severalfold
in conditions manifesting oxidant stress, such as uncon-
trolled diabetes mellitus [6] and smoking [10]. Intracellular
DHA concentrations have been measured in human lym-
phocytes, and found to be as much as 20% of ascorbate
concentrations [11]. Because ascorbate concentrations in
human blood monocytes are in the low-millimolar range
[12], DHA concentrations might be substantial. If so, then
intracellular DHA could serve as a significant source for
recycling to ascorbate, especially in cells undergoing oxidant
stress.
On the other hand, DHA is readily degraded due to
irreversible ring-opening. Intracellular DHA can also be
lost to the cells by efflux on the ubiquitous ‘‘GLUT’’ type
glucose transporters that mediate its uptake into cells [13].
Thus, the extent to which cells recycle the AFR relative to
DHA is important for ascorbate economy of the cell. Ined.
J.M. May et al. / Biochimica et Biophysica Acta 1640 (2003) 153–161154homogenates of several pig tissues, rates of AFR reduction
exceeded those of DHA reduction [14]. Reduction of the
AFR is catalyzed by microsomal [15–17] and mitochon-
drial [18] NADH-dependent cytochrome b5 reductases, and
by the NADPH-dependent enzyme thioredoxin reductase
[19]. These enzymes have high affinity for the AFR, in the
range of 10 AM or less, which is in the range of AFR
concentrations expected for cells undergoing oxidant stress
[20–22]. To address the question of relative rates of AFR
and DHA recycling, it is necessary to compare rates at
AFR and DHA concentrations that might be expected in
the cells.
In the present work, we evaluated the relative contri-
butions of recycling of ascorbate from the AFR and from
DHA using EA.hy926 cells. The latter is a permanent cell
line derived from human umbilical vein endothelial cells
that expresses factor VIII antigen [23], forms capillary-like
tubes in culture [24], oxidatively modifies human LDL
[25], and shows calcium-dependent stimulation of eNOS
[25]. We recently found that the redox cycling agent
menadione causes an oxidant stress that depletes both
ascorbate and DHA in these cells [26], suggesting that,
as in bovine aortic endothelial cells [3], DHA reduction is
at least partially dependent on GSH. In the present work,
we compared the mechanisms of ascorbate recycling
directly using cell lysates. We found that both NADH
and NADPH supported AFR reduction, and that NADPH-
dependent AFR reduction was due largely to thioredoxin
reductase. Maximal rates of enzyme-mediated reduction of
DHA were comparable to those of AFR reduction. Based
on these findings and on the stability and reactivity of the
AFR and DHA, we suggest that reduction of the AFR is
adequate to recycle ascorbate, except in cells under oxidant
stress, in which case DHA reduction serves as a second
line of defense.2. Materials and methods
2.1. Materials
Ascorbate oxidase (from Curcubita species), DHA, cyto-
chalasin B, and 2,3-dimercapto-1-propanol were from
Sigma/Aldrich Chemical (St. Louis, MO). The last two
reagents were prepared and stored as 5-mM solutions in
ethanol.
2.2. Cell culture and preparation for assays
EA.hy926 cells were provided by Dr. Cora Edgell (Uni-
versity of North Carolina, Chapel Hill, NC). Cells were
cultured in Dulbecco’s minimal essential medium that con-
tained 20 mM D-glucose, 10% (v/v) fetal bovine serum, and
HAT media supplement (Sigma/Aldrich Chemical). The
latter contains 5 mM hypoxanthine, 20 AM aminopterin,
and 0.8 mM thymidine in culture. Cell culture media wereprepared by the Cell Culture Core of the Vanderbilt Diabetes
Research and Training Center. Cells were cultured to con-
fluence for 18–24 h in 10-cm or six-well plates and rinsed
three times in Krebs–Ringer Hepes (KRH) buffer at 37 jC
before use in an experiment. The latter consisted of 20 mM
Hepes (N-2-hydroxyethylpiperazine N-2-ethanesulfonic
acid), 128 mM NaCl, 5.2 mM KCl, 1 mM NaH2PO4, 1.4
mM MgSO4, and 1.4 mM CaCl2, pH 7.4.
2.3. Measurement of intracellular ascorbic acid and DHA
Following incubation of cells in six-well plates, the me-
dium was aspirated, and the cells were quickly rinsed twice
with 2 ml of ice-cold KRH that contained 5 AM cytochalasin
B. These conditions were used to prevent the efflux of DHA
on glucose transporters during the rinsing steps. For assay of
ascorbate alone, the medium was removed and the mono-
layer was treated with 0.1 ml of 25% metaphosphoric acid
(w/v), followed by 0.35 ml of a buffer containing 0.1 M
Na2HPO4 and 0.05 mM EDTA, pH 8.0. For assay of total
ascorbate, both solutions contained 2 mM 2,3-mercapto-1-
propanol. The cells were scraped from the plate and the
lysate was microfuged 1 min at 14,000g at 3 jC. Aliquots
of the supernatant were taken for assay of ascorbic acid by
high-performance liquid chromatography with electrochem-
ical detection [27], except that tetrapentylammonium bro-
mide was used as the ion pair reagent. It was determined that
2 mM 2,3-dimercapto-1-propanol did not interfere with the
assay of ascorbate. Further, this concentration of 2,3-dimer-
capto-1-propanol was found to completely reduce 100 AM
DHA to ascorbate in 1 min under conditions of DHA
reduction. Intracellular concentrations of ascorbate were
calculated based on an intracellular water space in EA.hy926
cells of 3.6F1.2 Al/mg protein, as previously measured in
these cells [28].
2.4. Measurement of DHA and AFR reduction in cell lysates
Cells cultured to confluence on a 10-cm plate were rinsed
three times in 5 ml of KRH and scraped from the plate with
a rubber spatula in 2 ml of ice-cold KRH. This suspension
was subjected to two freeze–thaw cycles in dry ice/ethanol
and either used directly, or microfuged for 1 min at 4800g
at 3 jC. The slightly turbid supernatant was removed and
used for assay of AFR and DHA reduction at a final protein
concentration in the assay of about 0.1 mg/ml.
For assay of AFR reduction, lysate was incubated in a
semi-micro cuvette that contained phosphate-buffered sal-
ine (PBS, 12.5 mM Na2HPO4, 140 mM NaCl, pH 7.0) at
37 jC, 100 AM of either NADH or NADPH, 1 mM
ascorbate, the indicated concentration of ascorbate oxi-
dase, and other agents as noted. The cuvette was placed
in the sample chamber of a Beckman DU-640 recording
spectrophotometer at 37 jC, and the change in absorb-
ance at 340 nm was measured every 10 s for 3 min. The
linear rate of decrease in absorbance was calculated and
  
Fig. 1. Generation of the AFR by ascorbate and ascorbate oxidase. The
indicated concentration of ascorbate oxidase (AO, in units per ml, U/ml)
was incubated at 37 jC with 1 mM ascorbate in PBS at pH 7.0 and the
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using a coefficient of extinction of 6.22 mM1 cm1.
This rate was corrected in each experiment for the rate
observed with lysate and reduced nucleotide alone. This
correction was less than 10% of the total rate.
Assay of GSH-dependent DHA reduction was measured
by incubating supernatant from microfuged lysate (0.1 mg/
ml) in PBS at pH 7.0 with 0.4 U/ml glutathione reductase,
0.1 mM NADPH, 2 mM GSH (except where indicated), and
the noted concentration of freshly prepared DHA. Record-
ing and calculations were carried out as described for assay
of AFR reduction, and rates were corrected for rates of
direct reduction of DHA measured under the same condi-
tions in the absence of lysate.
2.5. Other methods
AFR generation from ascorbate and ascorbate oxidase
was measured spectrophotometrically by its absorbance at
360 nm, using an extinction coefficient of 3.3 mM1 cm1
[29]. Protein was measured by the method of Bradford [30].
Results are shown as meanFS.E. Statistical comparisons
were made using SigmaStat 2.0 software (Jandel Scientific,
San Rafael, CA). Differences between treatment groups
were assessed by one- or two-way analysis of variance with
post-hoc testing using Dunnett’s test.
absorption at 360 nm was followed for times noted in panel A. At each time
point, the concentration of the AFR was calculated as described in Materials
and methods. Results are shown as meanFS.E. from nine experiments. In
panel B, the average AFR concentration over the total 3-min incubation
from these data is plotted as a function of the ascorbate oxidase
concentration.3. Results
3.1. Generation and measurement of the AFR
To study the ability of EA.hy926 cells to regenerate
ascorbate from the AFR, it was necessary to use cell lysates,
in which the AFR can be generated by the combination of
ascorbate and ascorbate oxidase. The latter oxidizes ascor-
bate to the AFR, which then can be reduced back to
ascorbate, oxidized further to DHA, or can dismutate to
form a molecule of ascorbate and one of DHA from two
molecules of the AFR. First, to confirm the stability of AFR
concentrations when generated by the ascorbate/ascorbate
oxidase system, we measured AFR generation in buffer
alone by its absorbance of the AFR at 360 nm. As shown in
Fig. 1A, in the presence of 1 mM ascorbate, the steady-state
AFR concentration over 3 min was relatively constant,
although it did decrease about 10% at the highest oxidase
concentrations. The steady-state AFR concentration over 3
min showed a linear dependence on the concentration of
ascorbate oxidase (Fig. 1B).
To compare rates of AFR reduction by NADH and
NADPH, lysates of EA.hy926 cells microfuged briefly to
clear cell debris, then incubated with 5 U/ml of ascorbate
oxidase to generate an AFR concentration of about 6 AM.
As shown in Fig. 2A, there was increased disappearance
of both NADH and NADPH above background rates of
NAD(P)H disappearance in the absence of ascorbate andits oxidase. These changes reflect enzyme-dependent AFR
reduction. However, NADH was oxidized at only about
half the rate observed for NADPH. The possibility that
NADH-dependent activity present in particulate fractions
was lost during a 1-min microfuge step to clear large cell
fragments was tested by repeating the studies without the
microfuge step. As shown in Fig. 2B, relative rates of
NADH disappearance increased about 5-fold under these
conditions, and exceeded the rate of NADPH disappear-
ance, which increased only about 50%. This suggests that
most of the NADH-dependent AFR reductase activity was
in the particulate fractions, whereas most of the NADPH-
dependent activity was in the soluble fraction. In an
attempt to increase NADH-dependent AFR reduction even
further, the assays were carried out in the presence of
non-ionic detergents. However, both 0.2% Triton X-100
and 40 mM octyl-h-D-glucopyranoside decreased the
relative rates of NADH disappearance (Fig. 2B). The
Triton X-100 concentration was chosen based on the
results of a previous study that showed enhanced
NADH-dependent AFR reduction in mitochondria [9].
Lower concentrations of Triton X-100 were tried, but
either had no effect or were inhibitory (results not
shown).
Fig. 3. Dependence of thioredoxin-stimulated NADPH reduction on the
concentration of lysate protein. NADPH disappearance was followed in the
spectrophotometer at 37 jC in PBS containing increasing amounts of
EA.hy926 cell lysates, 5 AM thioredoxin, 1 mM ascorbate, and 5 U/ml
ascorbate oxidase. Results are shown from three experiments as meanFS.E.
for both the concentration of protein and the rate of NADPH disappearance.
Fig. 2. Pyridine nucleotide-dependent reduction of the AFR. Lysates (0.08–
0.15 mg protein/ml) were either microfuged briefly as described under
Materials and methods (panel A) or used directly (panel B). These were
mixed in PBS that contained 1 mM ascorbate, 5 U/ml ascorbate oxidase,
and one or more of the following as noted under the graph: NADH (100
AM), NADPH (100 AM), dithiothreitol (5 mM), thioredoxin (5 AM),
aurothioglucose (ATG, 10 AM), Triton X-100 (0.2% v/v), or octyl-h-D-
glucopyranoside (Octyl Glucoside, 40 mM). The rate of NAD(P)H
disappearance was followed spectrophotometrically at 340 nm for 3 min
at 37 jC and the rate of change in the concentration of NAD(P)H was
calculated as described under Materials and methods. Results are shown as
meanFS.E. from at least six experiments in panel A and from five
experiments in panel B. An asterisk (*) indicates P<0.05 compared to other
treatments in the same panel.
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was further investigated in the experiments shown in Fig.
2. First, to determine the extent to which reduction of
DHA (generated by dismutation of the AFR) contributed
to the rate of NADPH loss, 0.5 mM dithiothreitol was
included in the incubation. Dithiothreitol directly reduces
DHA to ascorbate, and thus should decrease or prevent
NADPH loss due to DHA reduction. As shown in the
third bar from the left in Fig. 2A, dithiothreitol did not
significantly affect rates of NADPH oxidation. This
suggests that there is little DHA either generated or
reduced under these conditions. In the presence of thio-
redoxin, a protein cofactor for thioredoxin reductase, rates
of NADPH disappearance tripled. When aurothioglucose
was added, rates of NADPH loss decreased by more than
75%. At the concentration of 10 AM used in thesestudies, aurothioglucose is a specific inhibitor of thiore-
doxin reductase [31]. Together, these results suggest that
most of the NADPH loss is due to thioredoxin reductase,
and that thioredoxin-stimulated rates of NADPH-depend-
ent AFR reduction are comparable to those observed
when NADH is the electron donor.
Additional features of NAD(P)H-dependent AFR re-
duction are shown in Figs. 3 and 4. First, there was very
little NADPH oxidized in the absence of lysate protein,
and the rate of oxidation increased linearly with lysate
protein (Fig. 3). Second, the apparent affinity of AFR
reduction using either NADH or NADPH as the electron
donor was in the low-micromolar range. This was
assessed by increasing the amount of ascorbate oxidase
(or the AFR) present in the incubation. Rates of both
NADH- and NADPH-dependent AFR reduction were
half-maximal at estimated AFR concentrations of 1–2
AM, based on non-linear fitting of the data to a rectan-
gular hyperbola (Fig. 4). The x-axis values in this figure
are the measured values and errors in the absence of cells
that are shown in Fig. 1. These results show that the
affinity of the NADPH-dependent thioredoxin reductase
system for the AFR is similar to that of NADH-dependent
reduction by enzymes in the particulate fraction.
3.2. Lysate reduction of DHA
To determine the extent to which DHA reduction con-
tributes to ascorbate recycling in EA.hy926 cells, we incu-
bated lysates of EA.hy926 cells with 0.1 mM DHA and a 5-
fold molar excess of GSH in the presence of glutathione
Fig. 5. Dependence of DHA reduction by GSH on the lysate protein
content. NADPH disappearance was followed as a function of the lysate
protein concentration in a coupled assay that measures NADPH
disappearance as oxidized GSH is recycled by glutathione reductase.
Reduction was followed in the spectrophotometer at 37 jC in PBS
containing 0.1 mM NADPH, 0.4 U/ml glutathione reductase, 0.5 mM GSH,
0.1 mM DHA, and the indicated concentration of cell lysate actually
measured in the experiments. Results are shown from seven experiments as
meanFS.E. for the rate of NADPH disappearance.
Fig. 4. Concentration dependence of AFR reduction. NADPH disappear-
ance (circles) was followed in the spectrophotometer at 37 jC in PBS
containing cell lysate supernatant (0.08–0.12 mg protein/ml), 0.1 mM
NADPH, 5 AM thioredoxin, 1 mM ascorbate, and increasing amounts of
ascorbate oxidase, as indicated. NADH disappearance (squares) was
followed in the same manner except that the crude lysate was used without
centrifugation (0.1–0.15 mg protein/ml) and 0.1 mM NADH was used
instead of NADPH. Results from at least six experiments are shown as
meanFS.E. The x-axis shows the estimated AFR concentration generated
from data of Fig. 1.
Fig. 6. Enzyme-dependent reduction of DHA by GSH in cell lysates.
Supernatants from cell lysates (0.08–0.12 mg protein/ml) were incubated at
37 jC in PBS that contained 0.1 mM NADPH, 0.4 U/ml glutathione
reductase, 2 mM GSH, and the indicated initial concentration of DHA. The
reaction was followed in the spectrophotometer as the disappearance of
NADPH. All values are corrected for the results in paired samples in which
reduction of DHAwas followed in the absence of lysate. Results are shown
as meanFS.E. from five experiments.
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by GSH, either directly or with the aid of one or more
enzymes, the resulting GSSG is recycled by glutathione
reductase with consumption of NADPH. As shown in Fig.
5, there was substantial direct reduction of DHA by GSH in
the absence of lysate. However, addition of increasing
amounts of lysate caused a linear increase in the extent of
NADPH oxidation, indicating that one or more enzymes
facilitate GSH-dependent DHA reduction. In subsequent
experiments, the direct reduction of DHA by GSH was
measured in the absence of lysate under the same condi-
tions, and the rate was subtracted from the corresponding
value measured in the presence of lysate. Under these
conditions, 10 AM aurothioglucose failed to inhibit GSH-
dependent NADPH oxidation, indicating little contribution
by the thioredoxin reductase system (results not shown).
Similarly, NADH did not serve as a substrate for GSH-
dependent AFR reduction (results not shown).
The reduction of a 0.1-mM concentration of DHA by the
lysates increased with increasing GSH concentrations up to
about 4 mM GSH (results not shown). Because the meas-
ured GSH concentration in these cells is about 2.0 mM [28],
this concentration was used to test the effects of increasing
amounts of added DHA on NADPH oxidation. As shown in
Fig. 6, the rate of NADPH disappearance increased in a
saturable manner when increasing amounts of DHA wereadded to the lysates. These results are corrected for non-
enzyme-dependent DHA reduction by GSH. The increase in
rates of NADPH disappearance was half-maximal at a DHA
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a rectangular hyperbola).
3.3. Intracellular ascorbate and DHA concentrations in
EA.hy926 cells
The question remains as to what concentrations of DHA
might be expected in endothelial cells. Therefore, intra-
cellular ascorbate and DHA concentrations were measured
in intact EA.hy926 cells following acute loading with DHA
and overnight loading with ascorbate. In the absence of
ascorbate loading, neither ascorbate nor DHAwere detected
in EA.hy926 cells (results not shown). However, when cells
were incubated with increasing amounts of DHA for 15
min, intracellular ascorbate increased into the low-millimo-
lar range (Fig. 7A, circles). Despite the increase in intra-
cellular ascorbate as a function of the DHA loading
concentration, the intracellular DHA concentration re-
mained about 20–30 AM (Fig. 7B, circles). Because acute
DHA reduction might be limited by depletion of cellular
reducing equivalents, ascorbate and DHA concentrations
were also measured in cells incubated overnight withFig. 7. Intracellular ascorbate and DHA concentrations in ascorbate-loaded
cells. For DHA treatment (circles, meanFS.E. from six experiments),
EA.hy926 cells in six-well plates were rinsed twice in warm KRH to
remove culture medium, and incubated for 15 min at 37 jC in KRH that
contained 5 mM D-glucose and the indicated initial DHA concentration. For
ascorbate treatment (squares, meanFS.E. from nine experiments), cells in
six-well plates were incubated for 14–16 h in complete culture medium
with the indicated ascorbate concentration. After completion of the
incubations, the cells were prepared for assay of DHA and ascorbate as
described under Materials and methods. Results of intracellular ascorbate
measurements are shown in panel A, and those from intracellular DHA
measurements are shown in panel B.ascorbate. With ascorbate loading, intracellular ascorbate
concentrations increased to levels similar to that observed
with acute DHA loading (Fig. 7A, squares). Intracellular
DHA concentrations following overnight ascorbate treat-
ment were comparable to those seen with acute DHA
loading (Fig. 7B, squares). Thus, although intracellular
DHA concentrations were a small fraction of ascorbate
concentrations, DHA was present after either acute loading
of the cells with DHA or overnight loading with ascorbate.
Further, intracellular DHA did not depend on the loading
concentration of either DHA or ascorbate.4. Discussion
The potential cellular mechanisms of ascorbate recycling
from both the AFR and DHA are diagramed in Fig. 8.
Human-derived endothelial cells reduced the AFR by both
NADH- and NADPH-dependent mechanisms. As expected
from previous studies showing NADH-dependent reduction
of the AFR by cytochrome b5 reductases in liver mitochon-
dria [18] and microsomes [15–17], partial removal of the
particulate fraction of lysates by a brief centrifugation also
decreased the amount of NADH-dependent AFR reductase
activity (Fig. 2A and B). When normalized to protein, rates
of NADH-dependent AFR reduction in EA.hy926 cell
lysates were similar to those observed in crude homogenates
of several pig tissues by Coassin et al. [14]. In contrast to
results of that study, use of non-ionic detergents decreased,
rather than increased, NADH-dependent AFR reductase
activity in particulate-containing fractions (Fig. 2B). This
may reflect better access of substrates to the particulate
enzymes in cultured endothelial cells than in crude tissue
homogenates.
In lysates of EA.hy926 cells that had been briefly micro-
fuged to remove particulate matter, NADPH was a better
electron donor for AFR reduction than was NADH (Fig. 2A).
NADPH-dependent AFR reduction was tripled by thiore-
doxin, and inhibited by aurothioglucose. These results sup-
port a role for thioredoxin reductase in cellular AFR
reduction. We previously found that purified rat liver thio-
redoxin reductase reduces the AFR with an affinity of about
2 AM [19]. The apparent affinity of thioredoxin-stimulated
NADPH-dependent AFR reductase activity is 1–2 AM in
EA.hy926 cell lysates (Fig. 4). Similarly, NADH-dependent
AFR reduction has a comparable affinity (Fig. 4), and is in
the range observed for NADH-dependent cytochrome b5
reduction of the AFR [15,18]. Further, maximal rates of
NADPH- and thioredoxin reductase-dependent AFR reduc-
tion observed in EA.hy926 cell lysates are similar to those
previously observed by us in overnight-dialyzed rat liver
homogenates under similar conditions [19]. They were also
comparable to rates of NADH-dependent AFR reduction in
EA.hy926 cell lysates containing cell particulate matter (Fig.
4), indicating that the thioredoxin system contributes sig-
nificantly to AFR reduction in these endothelial cells.
 Fig. 8. Schematic of intracellular ascorbate recycling. Ascorbate is attacked
by a radical species (X) that removes an electron and converts it to the
AFR. The AFR can undergo recycling back to the AFR via NADPH-
dependent reduction by thioredoxin reductase, or via NADH-dependent
reduction by either the microsomal or mitochondrial AFR reductases. DHA
is formed from the AFR either by dismutation of two molecules of the AFR
or further radical attack on the AFR (less likely). The resulting DHA can
then undergo two-electron reduction back to ascorbate by several
mechanisms. GSH-dependent reduction of DHA can be direct, or mediated
by GSH-dependent enzymes glutaredoxin or protein disulfide isomerase
(PDI). NADPH-dependent DHA reduction can be mediated by thioredoxin
reductase or by 3a-hydroxysteroid dehydrogenase [39].
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lysates was assessed in a coupled reaction with glutathione
reductase that measured the disappearance of NADPH.
However, to estimate enzyme-dependent DHA reduction,
it was necessary to correct for direct reduction of DHA by
GSH in each assay. We used a pH of 7.0 in the reaction to
attempt to decrease the rate of the non-enzymatic compo-
nent of DHA reduction, but it remained substantial (Fig.
5). Even after this correction, when normalized to protein,
corrected rates of GSH-dependent DHA reductase activity
in endothelial cells are severalfold greater than those
measured in crude homogenates of pig organs [14].
Although the thioredoxin reductase system can reduce
DHA to ascorbate at appreciable rates in rat liver homo-
genates [32], in this and previous studies in bovine aortic
endothelial cells [3] and human erythrocytes [33], we
found little contribution of thioredoxin reductase to DHA
reduction relative to that mediated by GSH.
Whether GSH-dependent DHA reductase activity has
physiologic relevance (e.g., relative to AFR reductase activ-
ity) depends on the kinetics of the reaction and the expected
intracellular DHA concentrations. DHA reductase activity
was saturable, with a half-maximal effect at an initial DHA
concentration of 100 AM (Fig. 6). Because the concentration
of DHA will decrease during the reaction due to its lack of
chemical stability, this value underestimates the actual affin-ity, or overestimates the DHA concentration at which activity
is half-maximal. To determine whether the apparent affinity
of DHA reductase activity in EA.hy926 cells corresponds to
intracellular concentrations of DHA might be present in cells
containing physiologic amounts of ascorbate, we measured
both DHA and ascorbate in cells that had been loaded with
each form of ascorbate. As expected, intracellular ascorbate
increased with the loading concentration of both DHA and
ascorbate (Fig. 7A). DHA was measured at 20–30 AM in
cells either loaded acutely with DHA, or loaded overnight
with ascorbate (Fig. 7B). The failure of intracellular DHA
concentrations to increase with increasing intracellular ascor-
bate concentrations could relate to a constant amount of
oxidant stress present in the cells in culture or during an acute
incubation. It seems clear from these results that increasing
intracellular ascorbate does not induce its own oxidation.
The measured intracellular DHA concentrations are appro-
priate for the maximal 100 AM apparent Km of the DHA
reductase activity. Further, in oxidatively stressed cells,
DHA concentrations would likely increase severalfold, and
would then fit the kinetics of glutaredoxin, which has an
apparent Km for DHA reduction of about 250 AM [34].
Our results address the question of the relative activ-
ities of DHA and AFR reductases in recycling ascorbate
in endothelial cells. Coassin et al. [14], found that rates of
AFR reduction in homogenates of several pig tissues were
severalfold greater than rates of enzyme-dependent DHA
reduction. At 2 mM GSH and 100 AM DHA, rates of
enzyme-dependent DHA reduction in EA.hy926 cells
(f10 nmol/mg/min) are similar to those observed for
the sum of maximal NADPH- and NADH-dependent AFR
reduction (f12 nmol/mg/min). Any contribution from
direct DHA reduction by GSH will add further to the
maximal capacity for GSH-dependent DHA reduction.
Nonetheless, enzyme-dependent AFR reduction in endo-
thelial and other cells is likely to be important because of
the unique chemistry of the AFR. Ascorbate participates
in one-electron reactions that necessarily generate the
AFR and not DHA [35]. Although the one-electron
reduction potential of DHA to form the AFR is lower
than for the AFR to form ascorbate [36], the AFR is
relatively unreactive [37] and thus will not compete well
with ascorbate for scavenging of such radicals. DHA
appears to be generated mostly from dismutation of two
molecules of the AFR to ascorbate and DHA [37,38].
High-affinity AFR reductases would thus be expected to
recycle the AFR before it could dismutate to DHA.
Although we can measure DHA in ascorbate-loaded
cultured endothelial cells, in the presence of lower oxygen
tensions in vivo, DHA concentrations inside cells might
also be much lower. Perhaps it is best to consider
ascorbate recycling as a two-step mechanism, such that
if the AFR escapes reduction, there are high-capacity,
low-affinity processes to reduce DHA before it escapes
the cells on glucose transporters or is irreversibly lost due
to ring-opening.
J.M. May et al. / Biochimica et Biophysica Acta 1640 (2003) 153–161160In conclusion, human-derived endothelial cells have
mechanisms for recycling ascorbate from both the AFR
and DHA. Both NADPH- and NADH-dependent enzymes
carry out high-affinity AFR reduction, whereas DHA reduc-
tion is largely GSH-dependent and due to both direct and
enzyme-dependent mechanisms. Because of its high affinity
and relatively high capacity, recycling of ascorbate from the
AFR is probably the most important mechanism in the
absence of severe oxidant stress. However, cultured endo-
thelial cells containing intracellular ascorbate have micro-
molar concentrations of DHA, so that in cells under oxidant
stress, recycling from DHA becomes a high-capacity second
line of defense against loss of ascorbate.Acknowledgements
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